Effects of Fuzheng Huayu Decoction on proteome in cirrhosis: Preliminary experimental study with rats

National Medical Journal of China

Volumn 87, Issue 18, 2007, Pages 1272-1275

  Liu, Jie ^a   Wang, Ji Yao ^b   Wei, Li Ming ^b   Lu, Ye ^b   Jin, Hong ^b  

^a FUDAN UNIVERSITY   (China)

^b NONE

Author keywords

Electrophoresis, gel; Fuzheng Huayu; Liver cirrhosis; Proteome; Two dimensional

Indexed keywords

APOLIPOPROTEIN A4; CARBON TETRACHLORIDE; CELL PROTEIN; CHINESE DRUG; COMPLEMENT COMPONENT C4; FUZHENG HUAYU; GLUTATHIONE PEROXIDASE; HAPTOGLOBIN; INTER ALPHA INHIBITOR H4 HEAVY CHAIN; LIVER REGENERATION RELATED PROTEIN LRRG03; MICROTUBULE ASSOCIATED PROTEIN 1; OLIVE OIL; PREALBUMIN; PROTEIN SERINE THREONINE KINASE; PROTEOME; UNCLASSIFIED DRUG; VIMENTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD SAMPLING; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; IMAGE ANALYSIS; INFERIOR CAVA VEIN; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER REGENERATION; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT; TWO DIMENSIONAL ELECTROPHORESIS;

ANIMALS; BLOOD PROTEINS; DRUGS, CHINESE HERBAL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; LIVER; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; PHYTOTHERAPY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 34447546853     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Chinese source.
2. Chinese source.
3. Chinese source.
4. Chinese source.
5. Chen C, Tien A, Chena JB. Preliminary proteome analysis of rabbit serum with hepatic failure. Enzyme Microb Technol, 2003, 33: 488-491.
6. Feng JT, Liu YK, Song HY. Heat-shock protein 27: a potential biomarker for hepatocellular carcinoma identified by serum proteome analysis. Proteomics, 2005, 5: 4581-4588.
7. Bjorhall K, Miliotis T, Davidsson P, et al. Comparison of different depletion strategies for improved resolution in proteomic analysis of human serum samples. Proteomics, 2005, 5: 307-317.
8. Abul H, Mathew TC, Dashti HM, et al. Level of superoxide dismutase, glutathione peroxidase and uric acid in thioacetamide induced cirrhotic rats. Anat Histol Embryol, 2002, 31: 66-71.
9. Britton RS, Bacon BR. Role of free radicals in liver diseases and hepatic fibrosis. Hepatogastroenterology, 1994, 41: 343-348.
10. Bianchi GP, Marchesini G, Brizi M, et al. Nutritional effects of oral zinc supplementation in cirrhosis. Nutrition Research, 2000, 20: 1079-1089.
11. Qin X, Swertfeger DK, Zheng S, et al. Apolipoprotein AIV: a potent endogenous inhibitor of lipid oxidation. Am J Physiol, 1998, 274: 1836-1840.
12. Arredouani M, Matthijs P, Van Hoeyveld E, et al. Haptoglobin directly affects T cells and suppresses T helper cell type 2 cytokine release. Immunology, 2003, 108: 144-151.
13. Pineiro M, Andres M, Iturralde M, et al. ITIH4 (inter-alpha-trypsin inhibitor heavy chain 4) is a new acute-phase protein isolated from cattle during experimental infection. Infect Immun, 2004, 72: 3777-3782.
14. Choi-Miura NH, Takahashi K, Yoda M, et al. The novel acute phase protein, IHRP, inhibits actin polymerization and phagocytosis of polymorphonuclear cells. Inflamm Res, 2000, 49: 305-310.
15. Bhanumathy CD, Tang Y, Monga SP, et al. ITIH-4, a serine protease inhibitor regulated in interleukin-6-dependent liver formation: role in liver development and regeneration. Dev Dyn, 2002, 223: 59-69.
16. Drewes G, Ebneth A, Preuss U, et al. MARK, a novel family of protein kinases that phosphorylate microtubule-associated proteins and trigger microtubule disruption. Cell, 1997, 89: 297-308.
17. Kato T, Satoh S, Okabe H, et al. Isolation of a novel human gene, MARKL1, homologous to MARK3 and its involvement in hepatocellular carcinogenesis. Neoplasia, 2001, 3: 4-9.
18. Hu L, Lau SH, Tzang CH, et al. Association of vimentin overexpression and hepatocellular carcinoma metastasis. Oncogene, 2004, 23: 298-302.
19. Chinese source.